Background Japan’s ‘Health Japan 21’ initiative targets a reduction in adult smoking prevalence to 12% by 2032. This study ...

Although tobacco undoubtedly contributes to this increase, Japan has done little to respond to this growing problem, and as a result lung cancer and other tobacco-related diseases are on the rise.

JPMorgan's assessment indicates that Japan Tobacco's shares do not show signs of being particularly undervalued when evaluated against dividend yield or price-to-earnings (P/E) ratio metrics. This ...

D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave” or the “Company”), a leader in quantum computing systems, software, and services, and the pharmaceutical division of Japan Tobacco Inc. (“JT ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

and the pharmaceutical division of Japan Tobacco Inc. (“JT”) today announced the completion of a joint proof-of-concept project that used quantum computing technology and artificial ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...